ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Vimovo, Filmtabletten - 60
61330008 Grünenthal Pharma AG
Vimovo, Filmtabletten06.05.2011
  06.05.2011
Naproxen and Esomeprazole (M01AE52) 
WHO-DDD 
07.10.20.60
07.10.20. 
B  
Yes 
IPCI
21.50No
    
10 %39.80
7680613300082Synthetika
  
Composition
naproxenum 500 mg, esomeprazolum 20 mg ut esomeprazolum magnesicum trihydricum 22.3 mg, carmellosum natricum conexum corresp. natrium 2.11 mg, povidonum K 90, silica colloidalis anhydrica, magnesii stearas, hypromellosum, macrogolum 8000, triethylis citras, polysorbatum 80, glyceroli monostearas 40-55, propylis parahydroxybenzoas ca. 10 µg, E 218 ca. 20 µg, triethylis citras, polysorbatum 80, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, polydextrosum, hypromellosum, macrogolum 8000, E 171, hypromellosum, macrogolum 8000, polysorbatum 80, Überzug: hypromellosum, macrogolum 8000, E 171, E 172 (flavum), hypromellosum, macrogolum 8000, cera carnauba, Drucktinte: E 172 (nigrum), propylenglycolum, hypromellosum, pro compresso obducto.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Esomeprazol20 mg
Naproxen500 mg
BAG: Active AgentDose
Esomeprazol20 mg
Naproxen500 mg
 
Inactive agentsDoseadditional_information
   
   
   
   
   
  color.
  Drucktinte
   
 40-55 
Hypromellosum  
Macrogol8000  
   
   
Polysorbatum 80  
 90  
   
Propylenglycol  
 10 µg 
Silica Colloidalis Anhydrica  
   
 
Source
Data was imported : 04.12.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home